SCHEMBL9703779

SCHEMBL9703779

CC1CC(=O)c2c(ccc(F)c2Cl)N1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 5/20 0.38
CREBBP Q92793 5/20 0.38
EP300 Q09472 1/20 0.38
AR P10275 2/20 0.35
PGR P06401 1/20 0.35
DAO P14920 1/20 0.35
CYP2C9 P11712 2/20 0.34
ADORA3 P0DMS8 1/20 0.33
KCNH2 Q12809 1/20 0.33
ALDH1A1 P00352 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SMARCA2 P51531 1/20 0.33
SMARCA4 P51532 1/20 0.33
PBRM1 Q86U86 1/20 0.33
PIM1 P11309 1/20 0.32
CLK4 Q9HAZ1 1/20 0.32
CSNK1G1 Q9HCP0 1/20 0.32
LMNA P02545 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10619645 0.85 CREBBP (0.41) BRD4CREBBPEP300ARPGR
SCHEMBL9704634 0.84 CREBBP (0.44) BRD4CREBBPEP300ARPGR
SCHEMBL15311795 0.77 HTR2C (0.39) BRD4CREBBPEP300PGRCYP2C9
SCHEMBL10914693 0.74 BRD4 (0.50) BRD4CREBBPEP300SMARCA2SMARCA4
SCHEMBL11724231 0.69 ACHE (0.47) BRD4CREBBPEP300ARPGR
SCHEMBL10401777 0.69 HTR2A (0.41) ARDAOALDH1A1SMN1; SMN2LMNA
SCHEMBL9704586 0.69 CREBBP (0.43) BRD4CREBBPEP300ARPGR
SCHEMBL11172350 0.68 HTR2C (0.40) ARPGR
SCHEMBL31170704 0.68 HTR2C (0.40) ARPGR
SCHEMBL10914586 0.68 CES1 (0.42) BRD4CREBBPEP300CYP2C9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4946844-A Optically active benzoquinolizine compounds, process for preparing same, and antibacterial preparation containing same as active ingredient TOKYO TANABE CO., LTD. (JP) 1990-08-07 US claimed
EP-0203795-B1 Benzo [i,j] quinolizine-2-carboxylic acid derivatives, the salts and their hydrates, pharmaceutical compositions thereof, and process for preparing the same TOKYO TANABE COMPANY LIMITED (JP) 1992-07-29 EP disclosed
US-4946844-A Optically active benzoquinolizine compounds, process for preparing same, and antibacterial preparation containing same as active ingredient TOKYO TANABE CO., LTD. (JP) 1990-08-07 US disclosed
EP-0323189-A2 Optically active benzoquinolizine compounds, process for preparing same, and antibacterial preparation containing same as active ingredient TOKYO TANABE COMPANY LIMITED (JP) 1989-07-05 EP disclosed
US-4720495-A Benzo[ij]quinolizine-2-carboxylic acids useful for treating bacterial infection TOKYO TANABE CO. LIMITED (JP) 1988-01-19 US disclosed
EP-0203795-A2 Benzo [i,j] quinolizine-2-carboxylic acid derivatives, the salts and their hydrates, pharmaceutical compositions thereof, and process for preparing the same TOKYO TANABE COMPANY LIMITED (JP) 1986-12-03 EP disclosed